The Emory University Autoimmunity Center of Excellence U19 will conduct basic and translational research on the B cell and autoantibody underpinnings of SLE and ether human autoimmune diseases. The function of this Administrative Cere A will be te provide support, organization, coordination and efficient management of the ACE. The goals of this Core are: 1. To provide oversight and guidance to all components and investigators of the ACE in order to ensure proper and timely fiscal management and use of human and financial resources. 2. To ensure that all investigators and support personnel are trained and accredited by the Emory Research Subject Review Board (RSRB) and that such training and accreditation is current as mandated by RSRB guidelines. A critical objective of this core will be to ensure patients safety and confidentiality. 3. To facilitate the Interaction between Emory ACE, the organizing center and the ACE Steering Committee. 4. To maximize the coordination and scientific progress of all projects. 5. To coordinate patient recruitment;sample collection and distribution;and data storage, management and sharing. These goals will be accomplished through close Interaction between Dr. Sanz (U19 and Core Director), the Core Manager (Ms. Scantlin) and the Business Administrator (Ms. Critchet), who will oversee grant accounfing support personnel and provide the liaison between the ACE, the NIH and the Emery University of Office of Sponsored Programs (OSP). They will coordinate efforts among Investigators and most Importantly, to ensure patients safety and confidentiality. Ms. Critchet will supervise the preparation and distribution of financial and administrative reports, develop and monitor budgets;monitor expenses and budgets ensuring costs are allowable, allocable, reasonable, and properly authorized. This structure will provide indispensable fiscal oversight and help with timely execution of strategic decisions made by the group. Relevance This Core will enable the Emory ACE U19 investigators to pursue critical research in human autoimmunity in an efficient, safe and productive fashion

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI110483-01
Application #
8732945
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
1
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
City
Atlanta
State
GA
Country
United States
Zip Code
30322
St Clair, E William; Baer, Alan N; Wei, Chungwen et al. (2018) Clinical Efficacy and Safety of Baminercept, a Lymphotoxin ? Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol 70:1470-1480
Tipton, Christopher M; Hom, Jennifer R; Fucile, Christopher F et al. (2018) Understanding B-cell activation and autoantibody repertoire selection in systemic lupus erythematosus: A B-cell immunomics approach. Immunol Rev 284:120-131
Putterman, Chaim; Pisetsky, David S; Petri, Michelle et al. (2018) The SLE-key test serological signature: new insights into the course of lupus. Rheumatology (Oxford) 57:1632-1640
Upadhyay, Amit A; Kauffman, Robert C; Wolabaugh, Amber N et al. (2018) BALDR: a computational pipeline for paired heavy and light chain immunoglobulin reconstruction in single-cell RNA-seq data. Genome Med 10:20
Jenks, Scott A; Cashman, Kevin S; Zumaquero, Esther et al. (2018) Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus. Immunity 49:725-739.e6
Hamilton, Jennie A; Wu, Qi; Yang, PingAr et al. (2018) Cutting Edge: Intracellular IFN-? and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells. J Immunol 201:2203-2208
Barwick, Benjamin G; Scharer, Christopher D; Martinez, Ryan J et al. (2018) B cell activation and plasma cell differentiation are inhibited by de novo DNA methylation. Nat Commun 9:1900
Asare, A; Kanaparthi, S; Lim, N et al. (2017) B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function. Am J Transplant 17:2627-2639
Fortner, Karen A; Bond, Jeffrey P; Austin, James W et al. (2017) The molecular signature of murine T cell homeostatic proliferation reveals both inflammatory and immune inhibition patterns. J Autoimmun 82:47-61
Sanz, Iñaki (2017) New Perspectives in Rheumatology: May You Live in Interesting Times: Challenges and Opportunities in Lupus Research. Arthritis Rheumatol 69:1552-1559

Showing the most recent 10 out of 33 publications